Brief: Dice Therapeutics Inc Shares Open 76.5% Above IPO Price In Nasdaq Debut
Sept 15 (Reuters) -
* DICE THERAPEUTICS INC SHARES OPEN AT $30.00 IN NASDAQ
DEBUT
VERSUS IPO PRICE OF $17.00/SHARE
Further company coverage: DICE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dice Therapeutics
See all newsBrief: Lilly Completes Acquisition Of Dice Therapeutics
Dice Therapeutics Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Eli Lilly Announces Extension Of Tender Offer To Acquire Dice
MoonLake Immunotherapeutics explores sale-sources
MoonLake Immunotherapeutics explores sale-sources